Sanofi Licenses Pozen Gastric Ulcer Combos

Sanofi has acquired a license to sell Pozen’s PA8140 and PA32540 tablets, integrated aspirin therapies that aim to reduce gastric ulcers in patients with cardiovascular disease.
Pharma Times